Comparison of Angiotensin-Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) for Heart Failure Treatment in Congenital Heart Diseases with Left-to-Right Shunt

• Main Authors: I Ketut Alit Utamayasa, -, Mahrus A. Rahman, -, Teddy Ontoseno, -, Budiono, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Prodia Education and Research Institute 2020
• Subjects: R Medicine (General); RJ Pediatrics
• Online Access: https://repository.unair.ac.id/109023/1/Comparison%20of%20angiotensin-converting%20enzyme%20inhibitor%20%28ACEI%29%20and%20angiotensin%20receptor%20blocker%20%28ARB%29%20for%20heart%20failure%20treatment%20in%20congenital%20heart%20diseases%20with%20left-to-right%20shunt.pdf; https://repository.unair.ac.id/109023/2/Comparison%20of%20Angiotensin.pdf; https://repository.unair.ac.id/109023/3/Comparison%20of%20angiotensin-converting%20enzyme%20inhibitor%20%28ACEI%29%20and%20angiotensin%20receptor%20blocker%20%28ARB%29%20for%20heart%20failure%20treatment%20in%20congenital%20heart%20diseases%20with%20left-to-right%20shunt.pdf; https://repository.unair.ac.id/109023/6/16.pdf; https://repository.unair.ac.id/109023/; https://inabj.org/index.php/ibj/article/view/997; https://doi.org/10.18585/inabj.v12i1.997
• Institution: Universitas Airlangga

BACKGROUND: The angiotensin-converting enzyme inhibitors (ACEIs) have become the forefront of heart failure treatment for more than a decade. Currently, angiotensin receptor blockers (ARBs) are thought to have similar effectiveness. This study aimed to compare the impact of captopril, one of ACEI, a...